Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Undergraduate: Mobility, musculoskeletal health and arthritis - ICS

University of Ottawa

$4,950.00

Examining the role of HDAC4/5 in skeletal myogenesis in P19 cells

FY 2009-10

Summary
Stem cell therapy is a treatment possibility that involves using differentiated stem cells to replace damaged cells. Stem cells have the potential to differentiate into many cell types, however directing them into a specific lineage in high proportions is challenging. This project aims to increase the efficiency of skeletal muscle differentiation by manipulating histone deacetylase (HDAC) genes. More specifically, I am going to knock down HDAC4/5 to see if this can enhance skeletal muscle differentiation.
Program
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
205289
Name
Sendi-Mukasa Flavia M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Undergraduate: Mobility, musculoskeletal health & arthritis - IMHA
Projecttitle
Examining the role of HDAC4/5 in skeletal myogenesis in P19 cells
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$4,950
Cihrequipment2
$0
Programname2
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Keyworddelim
Hdac4 And Hdac5; Shrna Knockdown; Stem Cell Culture
Abstract
Stem cell therapy is a treatment possibility that involves using differentiated stem cells to replace damaged cells. Stem cells have the potential to differentiate into many cell types, however directing them into a specific lineage in high proportions is challenging. This project aims to increase the efficiency of skeletal muscle differentiation by manipulating histone deacetylase (HDAC) genes. More specifically, I am going to knock down HDAC4/5 to see if this can enhance skeletal muscle differentiation.
Competitiondate
201003
Approvedterm2
0 yr 3 mths
Pinamesdelim
Sendi-Mukasa, Flavia M
Approvedterm
0 an 3 mois
Cihrcontribution2
~ $4,950~ $0~